Items where authors include "Varughese, M"

Article

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Catto, JWF, Downing, A orcid.org/0000-0002-0335-7801, Mason, S et al. (9 more authors) (2021) Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes. European Urology, 79 (5). pp. 621-632. ISSN 0302-2838

Mateo, J, Porta, N, Bianchini, D et al. (38 more authors) (2020) Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. The Lancet Oncology, 21 (1). pp. 162-174. ISSN 1470-2045

Conference or Workshop Item

Huddart, R, Hafeez, S, Omar, A et al. (22 more authors) (2021) Acute toxicity of hypo- and conventionally-fractionated radiosensitised bladder radiotherapy. In: ESTRO 2021, 28-31 Aug 2021, Madrid, Spain & Online.

Proceedings Paper

Hunt, A, Chan, A, Delacroix, L et al. (21 more authors) (2019) Establishing international variation in target delineation using MRI for bladder radiotherapy. In: Radiotherapy and Oncology. ESTRO 38, 26-30 Apr 2019, Milan, Italy. Elsevier BV , S857-S858.